Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Total 13F shares
-
34,931,072
-
Share change
-
+1,020,973
-
Total reported value
-
$510,109,820
-
Put/Call ratio
-
53%
-
Price per share
-
$14.60
-
Number of holders
-
93
-
Value change
-
-$6,734,814
-
Number of buys
-
60
-
Number of sells
-
28
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2022
As of 30 Jun 2022,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,931,072 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, Abingworth LLP, BlackRock Inc., Cormorant Asset Management, LP, Polar Capital Holdings Plc, VANGUARD GROUP INC, DAFNA Capital Management LLC, and Deep Track Capital, LP.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.